As if there hasn’t been enough confusion around the COVID-19 vaccine and booster, yet another change in plans seems to be on the horizon.
A top Food and Drug Administration official said Tuesday that updated data might make a strong case that everyone 18 and older should be eligible for coronavirus vaccine boosters but the agency will have to see whether its outside advisers agree.
The remarks from Peter Marks, director of the Center for Biologics Evaluation and Research, came on a webinar as the FDA prepares to meet Oct. 14 and 15 with its outside advisers to discuss boosters for the Moderna and Johnson & Johnson vaccines.
Biden administration health officials in mid-August said the nation should prepare for giving boosters to all adults in the United States. But when considering a request by Pfizer-BioNTech to authorize boosters, the FDA’s advisers last month balked at such a broad approach.
The FDA then authorized the extra shot for everyone 65 and older who had received the two-dose Pfizer regimen, and for others with medical conditions or occupations and living situations that made them more likely to have a serious outcome from covid-19, the illness caused by the coronavirus.
Contact Jay Allen at [email protected]